COMPARE Pilot: No difference between two DCBs in 2-year patency - Healio

COMPARE Pilot: No difference between two DCBs in 2-year patency  Healio

HOLLYWOOD, Fla. — Two-year results from the first 150 patients in the COMPARE Pilot study show similar patency with two drug-coated balloons for the ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more